Delivery Order SPE2DB24D2100-SPE2DB24FBDNA

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Tagrisso 80 mg tablets. The contract has a ceiling value of $10,538.79 and a completion date of September 17, 2024. This contract is not set aside for any specific business category. As a large pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain network to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the major pharmaceutical distributor AmerisourceBergen Drug Corporation. The contract is for the supply of Tagrisso 80 mg tablets, a specialty cancer medication, valued at $21,077.60. The contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, a leading provider of pharmaceutical and medical supplies to the U.S. government, has been awarded numerous indefinite delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the prescription medication Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,538.79, is for the delivery of the pharmaceuticals product Tagrisso 80 mg Tablet 30s. This is a firm fixed price delivery order contract with an ultimate completion date of April 18, 2024. AmerisourceBergen Drug Corp holds an Indefinite...
This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the medication Tagrisso 40 mg Tablet 30s. The contract has a ceiling value of $31,524.93 and is a firm fixed-price agreement with a period of performance through September 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp's Corporate Office division is the prime contractor for this award, which is a task...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product TAGRISSO 40 MG TABLET 30S. The contract does not have a set-aside designation and has a ceiling value of $10,508.31 with a period of performance through October 30, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $136,227.90 delivery order is for the supply of Tagrisso 80 MG tablets, a prescription medication. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price delivery order. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed price delivery order is for TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDNA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Tagrisso 80 mg tablet medication, with a ceiling value of $10,538.79 and a period of performance through October 3, 2024. As a large pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of prescription drugs, medical supplies, and equipment to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This specific contract does not have a set-aside designation. The DLA is the primary customer for AmerisourceBergen's federal contracting activities, with a significant IDC valued up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to the military.

Generated 12/12/24, 10:13 AM